all report title image

SEASONAL AFFECTIVE DISORDER MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Seasonal Affective Disorder Market, By Type (Fall & Winter Seasonal Affective Disorder, Spring & Summer Seasonal Affective Disorder, and Others), By Treatment (Light Therapy, Medications, Psychotherapy, Counselling, and Others), By End User (Hospitals, Clinics, Research Institutes, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

  • Published In: 30 Apr, 2026
  • Code: CMI4333
  • Page number: 154
  • Formats:   Excel and PDF
  • Industry: Pharmaceutical
    • Historical Range : 2020 - 2024
    • Base Year : 2025
    • Estimated Year : 2026
    • Forecast Period : 2026 - 2033
Ingographics Image

Table of Contents (Version-2026)

  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Type
      • Market Snippet, By Treatment
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Pipeline Analysis
    • Reimbursement Scenario
    • Epidemiology
    • Pest Analysis
    • Regulatory Scenario
    • New Product Launches
    • Collaborations and Agreements
    • Market Trends
  4. Global Seasonal Affective Disorder Market, By Type, 2021 – 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026, and 2033 (%)
      • Y-o-Y Growth Analysis, 2022-2033
      • Segment Trends
    • Fall & Winter Seasonal Affective Disorder
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Spring & Summer Seasonal Affective Disorder
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  5. Global Seasonal Affective Disorder Market, By Treatment, 2021 – 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026, and 2033 (%)
      • Y-o-Y Growth Analysis, 2022-2033
      • Segment Trends
    • Light Therapy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Medications
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Psychotherapy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Counselling
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  6. Global Seasonal Affective Disorder Market, By End User, 2021 – 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026, and 2033 (%)
      • Y-o-Y Growth Analysis, 2022-2033
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Research Institutes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  7. Global Seasonal Affective Disorder Market, By Region, 2021 – 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, By Region, 2026, and 2033 (%)
      • Y-o-Y Growth Analysis, For Regions, 2022–2033
    • North America
      • Market Size and Forecast, By Type, 2021-2033, (USD Bn)
      • Market Size and Forecast, By Treatment, 2021-2033, (USD Bn)
      • Market Size and Forecast, By End User, 2021-2033, (USD Bn)
      • Market Size and Forecast, By Country, 2021-2033, (USD Bn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Type, 2021-2033, (USD Bn)
      • Market Size and Forecast, By Treatment, 2021-2033, (USD Bn)
      • Market Size and Forecast, By End User, 2021-2033, (USD Bn)
      • Market Size and Forecast, By Country, 2021-2033, (USD Bn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Type, 2021-2033, (USD Bn)
      • Market Size and Forecast, By Treatment, 2021-2033, (USD Bn)
      • Market Size and Forecast, By End User, 2021-2033, (USD Bn)
      • Market Size and Forecast, By Country, 2021-2033, (USD Bn)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Type, 2021-2033, (USD Bn)
      • Market Size and Forecast, By Treatment, 2021-2033, (USD Bn)
      • Market Size and Forecast, By End User, 2021-2033, (USD Bn)
      • Market Size and Forecast, By Country, 2021-2033, (USD Bn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Market Size and Forecast, By Type, 2021-2033, (USD Bn)
      • Market Size and Forecast, By Treatment, 2021-2033, (USD Bn)
      • Market Size and Forecast, By End User, 2021-2033, (USD Bn)
      • Market Size and Forecast, By Country, 2021-2033, (USD Bn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Type, 2021-2033, (USD Bn)
      • Market Size and Forecast, By Treatment, 2021-2033, (USD Bn)
      • Market Size and Forecast, By End User, 2021-2033, (USD Bn)
      • Market Size and Forecast, By Country, 2021-2033, (USD Bn)
        • South Africa
        • Central Africa
        • North Africa
  8. Competitive Landscape

    • Heat Map Analysis
    • Market Share Analysis
      • Pfizer, Inc
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • GlaxoSmithKline plc
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Johnson & Johnson Services Inc
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Novartis AG
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Sanofi
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Teva Pharmaceutical Industries Ltd
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Eli Lily and Company
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • AbbVie Inc
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Hoffmann-La Roche AG
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Mylan, Inc
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Bausch Health
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Koninklijke Philips N.V.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Bayer AG
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Allergan
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Bristol-Myers Squibb
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Henry Schein Inc
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
    • Analyst Views
  9. Section

    • References
    • Research Methodology
    • About us and Sales Contact
  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
Logo

Credibility and Certifications

DUNS Registered

860519526

ESOMAR
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

Clutch
Credibility and Certification

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2026 Coherent Market Insights Pvt Ltd. All Rights Reserved.